SCHRODER INVESTMENT MANAGEMENT GROUP

Position in CYTK — Cytokinetics Inc

CIK 1086619 London, X0

Position in CYTK

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$11,935,033

+$10,741,206 QoQ

Shares Held

140,099

+673.5% QoQ

Ownership

0.101%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#113

of 477 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $692,439,062 across 60 Biotechnology names. CYTK ranks #18 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	1,410,943	$99,683,122
2	VRTX	Vertex Pharmaceuticals Inc / Ma	169,270	$84,081,485
3	EXEL	Exelixis, Inc.	669,005	$36,400,560
4	INSM	INSMED Inc	298,372	$31,812,422
5	ALNY	Alnylam Pharmaceuticals, Inc.	95,194	$28,656,248
6	MDGL	Madrigal Pharmaceuticals, Inc.	51,630	$27,722,728
7	VERA	Vera Therapeutics, Inc.	510,787	$21,917,869
8	TVTX	Travere Therapeutics, Inc.	379,611	$21,565,700

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,935,033	140,099	+673.5%	Shares	Sole	2026-08-13
2026-03-31	$1,193,827	18,113	-90.3%	Shares	Sole	2026-05-14
2025-09-30	$10,271,089	186,883	-39.9%	Shares	Sole	2025-11-13
2025-06-30	$10,271,838	310,891	-10.0%	Shares	Sole	2025-08-13
2025-03-31	$13,889,583	345,598	+131.3%	Shares	Sole	2025-05-13
2024-12-31	$7,029,327	149,433	+10.1%	Shares	Sole	2025-02-12
2024-09-30	$7,166,279	135,725	-46.5%	Shares	Sole	2024-11-13
2024-06-30	$13,733,925	253,487	0.0%	Shares	Sole	2024-08-12
2024-03-31	$17,771,973	253,487	+128.1%	Shares	Sole	2024-05-14
2023-12-31	$9,279,663	111,147	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.